Wednesday, July 30, 2025

Creating liberating content

Introducing deBridge Finance: Bridging...

In the dynamic landscape of decentralized finance (DeFi), innovation is a constant,...

Hyperliquid Airdrop: Everything You...

The Hyperliquid blockchain is redefining the crypto space with its lightning-fast Layer-1 technology,...

Unlock the Power of...

Join ArcInvest Today: Get $250 in Bitcoin and a 30% Deposit Bonus to...

Claim Your Hyperliquid Airdrop...

How to Claim Your Hyperliquid Airdrop: A Step-by-Step Guide to HYPE Tokens The Hyperliquid...
HomeHealthcareBoots, Superdrug and...

Boots, Superdrug and Covonia withdrawn from cough and cold medicines due to safety concerns

Cough and cold medicines containing pholcodine have been discontinued for safety reasons.

The drugs were recalled after a review found that the risk of a very rare allergic reaction associated with pholcodine outweighed the health benefits of the drug.

An allergic reaction has been described as a “very rare occurrence” of anaphylaxis in patients receiving general anesthesia with muscle relaxants (muscle relaxants).

The Medicines and Healthcare Products Regulatory Agency (MHRA) has ordered healthcare professionals to stop dispensing these drugs and recommend other products to patients instead.

People who are currently taking lozenges or cough syrups should check the package to see if pholcodine is on the ingredient list and speak to their pharmacist for more information. People should also tell their anesthesiologist before surgery if they have taken pholcodine within the past 12 months, the MHRA said.

The MHRA press release says there is already a known link between a rare severe allergic reaction that occurs under general anesthesia and that the results of a new study from September 2022 confirmed the evidence, while noting that the overall risk is “very small”. “was previously. “.

MHRA Chief Security Officer Dr. Alison Cave said in a statement: “Safety is our top priority and we are constantly monitoring drug safety.

“Following a thorough scientific safety review of all available data on pholcodine, as well as the recommendation of the Independent Medicines Committee, it has been recommended that these products be no longer used as a precautionary measure.”

Drugs affected by the recall

  • Boots Night Cough Relief oral solution
  • Boots dry cough syrup 6 years +
  • Boots Day oral solution for colds and flu
  • Chosen Linctus
  • Care Pholcodine 5 mg / 5 ml sugar free oral solution
  • Galenhall Lincoln
  • Galenfol Pediatric Linctus
  • Galenfall Strong Linctus
  • Covonia Sugar Free Dry Cough Formula
  • Pholcodine Linctus Bells Healthcare 5 mg per 5 ml oral solution
  • Numark Folcodin 5 mg per 5 ml oral solution
  • Superdrug Folcodin Linctus BP
  • Strong Pholcodin Linctus BP
  • Polcodin Linctus BP
  • Strong Pholcodin Linctus BP

According to the MHRA, pholcodine is an opioid drug used to treat dry coughs in adults and children over the age of six, and in combination with other drugs to treat cold and flu symptoms. This works directly in the brain and suppresses the cough reflex by reducing the nerve signals sent to the muscles involved in coughing.

Source: I News

Get notified whenever we post something new!

Continue reading

8 out of 10 asthmatics did not receive the recommended two-day follow-up visit

The study found that more than 8 in 10 patients with asthma did not receive standard care, and the situation was even worse for black patients. Just 18 percent of asthma patients admitted to hospital saw their GP within the...

The Covid JN.1 variant continues to spread as UK case numbers approach record levels.

The highly contagious JN.1 subvariant continues to spread across the UK and is now responsible for almost two thirds of all new Covid cases, figures show. The number of JN.1 infections has risen sharply in recent weeks, from 4 percent...

Which health app is better? We tried Zoe, Fast 800 and MyFitnessPal.

Whether it's a pedometer, a sleep tracker, or a doctor's appointment system, chances are you have a health app on your smartphone. Health and wellness apps are big business: the market was valued at around €36 billion in 2022...